Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2017 000 034.2 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Obeticholsäure |
54 | Title of basic patent | TIGZ | STEROIDE ALS AGONISTEN FÜR FXR |
51 | IPC main class | ICM (ICMV) | C07J 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/575 (2006.01), A61P 9/10 (2006.01) |
94 | Start of term of protection | LB | Feb 22, 2022 |
94 | End of term of protection | LE | Feb 21, 2027 |
22 | DE application date | DAT | May 22, 2017 |
| Date of publication of application for a certificate | OT | Aug 17, 2017 |
| Date of publication of grant of certificate | PET | Aug 16, 2018 |
71/73 | Applicant/owner | INH | Intercept Pharmaceuticals, Inc., 10 Hudson Yards, 37th FL, 10001 New York, N.Y., US |
74 | Representative | VTR | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
| Address for service | | GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE |
| Due date | FT FG | Feb 28, 2026 Annual fee for the 25th year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 602 05 891.0 |
68 | EP file number of basic patent | GEAKZ | 02 75 0526.2 |
43 | Date of first publication | EVT | Aug 17, 2017 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/16/1139 2016-12-12
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/16/1139 2016-12-12
|
| Date of the first transfer into DPMAregister | EREGT | Aug 17, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 7, 2025 (Show all update days)(Hide all update days)- Feb 7, 2025
- Aug 13, 2024
- St.36: changed (technical change)
- Feb 8, 2024; Feb 8, 2023; Feb 10, 2022; Jan 25, 2022; Apr 20, 2021; Mar 5, 2021; Jul 16, 2019; Aug 16, 2018; Jul 10, 2018; May 4, 2018
- Historical data not available for this/these date(s)
- Aug 17, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 1)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 28, 2017 |
71/73 | Applicant/owner | INH | Intercept Pharmaceuticals, Inc., 10001 New York, N.Y., US |
71/73 | Previous applicant/owner | INHF | Intercept Pharmaceuticals, Inc., New York, NY, US |
| Date of update of the procedure | REGT | Apr 20, 2021 |